SALMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,675,901 | 1,649,776 | 1,798,804 | 1,544,568 | 2,316,394 | 3,274,570 | 2,807,747 | 2,502,292 |
| Profit before tax | 293,143 | 189,656 | 373,417 | 250,340 | 352,045 | 392,786 | 242,289 | 100,417 |
| Net profit | 252,242 | 162,096 | 317,624 | 212,784 | 299,194 | 334,234 | 205,883 | 84,789 |
| Equity | 796,587 | 758,683 | 956,307 | 919,091 | 1,018,285 | 1,152,520 | 1,263,403 | 1,597,635 |
| Liabilities | 467,511 | 637,815 | 327,993 | 354,974 | 403,648 | 641,645 | 444,096 | 148,974 |
| Non-current assets | 243,059 | 200,569 | 175,414 | 144,917 | 161,623 | 340,990 | 268,980 | 166,083 |
| Current assets | 1,016,709 | 1,191,143 | 1,107,472 | 1,125,615 | 1,265,300 | 1,451,733 | 1,436,322 | 1,671,879 |
| Total assets | 1,259,768 | 1,391,712 | 1,282,886 | 1,270,532 | 1,426,923 | 1,792,723 | 1,705,302 | 1,837,962 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 747,465 | 659,588 | 571,785 |
| Social insurance contributions | - | - | - | - | - | 88,561 | 91,455 | 116,795 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.9% | -1.6% | +9.0% | -14.1% | +50.0% | +41.4% | -14.3% | -10.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.0% | 11.6% | 24.8% | 16.7% | 21.0% | 18.6% | 12.1% | 4.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 31.7% | 21.4% | 33.2% | 23.2% | 29.4% | 29.0% | 16.3% | 5.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.1% | 9.8% | 17.7% | 13.8% | 12.9% | 10.2% | 7.3% | 3.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.5% | 11.5% | 20.8% | 16.2% | 15.2% | 12.0% | 8.6% | 4.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.8 | 0.3 | 0.4 | 0.4 | 0.6 | 0.4 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 174,877 | 176,762 | 199,867 | 176,522 | 289,549 | 367,240 | 336,931 | 254,471 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SALMEDA - Social security debts
The company had no debts to Sodra
SALMEDA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-05 | 2025-05-13 | 963.44 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SALMEDA, UAB (code 123500866) is a Private Limited Liability Company operating in wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 2.50 million in revenue, down 10.9% year on year and 23.6% below the 2023 level. Net profit declined to EUR 84.8 thousand from EUR 205.9 thousand in 2024 and EUR 334.2 thousand in 2023, while the net profit margin narrowed to 3.4% from 7.3% and 10.2% in the previous two years. Profit before tax followed the same downward pattern, reaching EUR 100.4 thousand in 2025. Despite lower earnings, equity increased to EUR 1.60 million, while liabilities fell to EUR 149.0 thousand. Total assets stood at EUR 1.84 million, supported mainly by short-term assets of EUR 1.67 million. The equity ratio was 86.9% and debt-to-equity 0.09, indicating a very strong balance sheet position. Return on equity was 5.3% and return on assets 4.6%. Revenue per employee was EUR 278.0 thousand, with profit per employee at EUR 9.4 thousand.